Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 2, 2013, Pages 135-142

  Kang, Fubiao ^a   Chen, Weiwei ^a   Zhang, Xinwei ^a   Nie, Weimin ^a   Fu, Junliang ^a   Xu, Xiangsheng ^a   Zhao, Peng ^a   Li, Wengang ^a   Wang, Fu Sheng ^a   Zhang, Zheng ^a   Zhao, Min ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

HARRT; HCV specific T cell response; HIV 1 HCV coinfection; liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; DIDANOSINE; GAMMA INTERFERON; LAMIVUDINE; LOPINAVIR; PROTEIN NS3A; RITONAVIR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIVER INJURY; MALE; MIXED INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; LIVER; MALE; MIDDLE AGED; RNA, VIRAL; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; VIRAL CORE PROTEINS; VIRAL LOAD; YOUNG ADULT;

EID: 84872875614     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182752d20     Document Type: Article

References (27)

1. Thomas DL. The challenge of hepatitis C in the HIV-infected person. Annu Rev Med. 2008;59:473-485. (Pubitemid 351287950)
2. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a metaanalysis. Clin Infect Dis. 2001;33:562-569. (Pubitemid 32709592)
3. Rauch A, Gaudieri S, Evison J, et al. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antivir Ther. 2008;13:455-460. (Pubitemid 352016738)
4. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800-1805.
5. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632-1641. (Pubitemid 44232373)
6. Kontorinis N, Dieterich D. Hepatotoxicity of antiretroviral therapy. AIDS Rev. 2003;5:36-43. (Pubitemid 36873893)
7. Ogedegbe AO, Sulkowski MS. Antiretroviral-associated liver injury. Clin Liver Dis. 2003;7:475-499. (Pubitemid 36807742)
8. Pineda JA, Macias J, Mira JA, et al. HAART and the liver: friend or foe? Eur J Med Res. 2010;15:93-96.
9. Klenerman P, Lucas M, Barnes E, et al. Immunity to hepatitis C virus: stunned but not defeated. Microbes Infect. 2002;4:57-65. (Pubitemid 34127992)
10. Harcourt G, Gomperts E, Donfield S, et al. Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Gut. 2006;55:1484-1487. (Pubitemid 44476795)
11. Kim AY, Schulze zur Wiesch J, Kuntzen T, et al. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 2006;3:e492.
12. Lauer GM, Barnes E, Lucas M, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127:924-936. (Pubitemid 39208424)
13. Kim AY, Lauer GM, Ouchi K, et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood. 2005; 105:1170-1178. (Pubitemid 40170890)
14. Dutoit V, Ciuffreda D, Comte D, et al. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol. 2005;35:3493-3504. (Pubitemid 43025531)
15. Rohrbach J, Robinson N, Harcourt G, et al. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut. 2010;59:1252-1258.
16. Thein HH, Yi Q, Dore GJ, et al. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008;22: 1979-1991.
17. Contreras AM, Hiasa Y, He W, et al. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol. 2002;76:8505-8517. (Pubitemid 34864045)
18. Fitzmaurice K, Klenerman P. Cellular immunity and acute hepatitis C infection. Curr Pharm Des. 2008;14:1666-1677. (Pubitemid 351998591)
19. Cooper CL, Cameron DW. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis. 2002; 35:873-879.
20. Braitstein P, Palepu A, Dieterich D, et al. Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. AIDS. 2004;18:2221-2234. (Pubitemid 39620214)
21. Fialaire P, Payan C, Vitour D, et al. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. J Infect Dis. 1999;180: 574-575. (Pubitemid 30256353)
22. Falconer K, Gonzalez VD, Reichard O, et al. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol. 2008;41:160-163.
23. Torti C, Barnes E, Quiros-Roldan E, et al. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection. Antivir Ther. 2004;9:139-142. (Pubitemid 38313957)
24. Weissbrich B, Langmann P, Schubert J, et al. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flareups. Eur J Med Res. 2003;8:495-498.
25. Yokozaki S, Takamatsu J, Nakano I, et al. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood. 2000;96: 4293-4299.
26. Qurishi N, Kreuzberg C, Luchters G, et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708-1713. (Pubitemid 37468321)
27. Page EE, Nelson M, Kelleher P. HIV and hepatitis C coinfection: pathogenesis and microbial translocation. Curr Opin HIV AIDS. 2011; 6:472-477.